Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,300 | 515 | 99.7% |
| Education | $24.79 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,143 | 66 | $0 (2024) |
| ABBVIE INC. | $1,028 | 72 | $0 (2024) |
| PFIZER INC. | $666.61 | 37 | $0 (2023) |
| Novo Nordisk Inc | $598.09 | 39 | $0 (2024) |
| Amarin Pharma Inc. | $427.65 | 49 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $427.22 | 23 | $0 (2023) |
| Antares Pharma, Inc. | $370.82 | 27 | $0 (2024) |
| Lilly USA, LLC | $366.31 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $321.88 | 22 | $0 (2024) |
| Allergan, Inc. | $269.18 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $551.53 | 24 | AstraZeneca Pharmaceuticals LP ($177.13) |
| 2023 | $557.70 | 33 | ABBVIE INC. ($225.11) |
| 2022 | $586.15 | 36 | ABBVIE INC. ($182.55) |
| 2021 | $1,648 | 102 | AbbVie Inc. ($397.86) |
| 2020 | $1,510 | 99 | PFIZER INC. ($222.99) |
| 2019 | $920.13 | 60 | Antares Pharma, Inc. ($220.29) |
| 2018 | $1,093 | 72 | AstraZeneca Pharmaceuticals LP ($143.15) |
| 2017 | $1,458 | 92 | AstraZeneca Pharmaceuticals LP ($213.98) |
All Payment Transactions
518 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 12/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Oncology | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: VACCINES | ||||||
| 09/07/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: HIV | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Biological | ||||||
| 07/23/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $18.52 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: VACCINES | ||||||
| 05/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Respiratory | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: Respiratory | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Respiratory | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,288 | 1,782 | $563,385 | $159,558 |
| 2022 | 12 | 1,180 | 1,752 | $678,903 | $145,443 |
| 2021 | 12 | 1,069 | 1,588 | $608,368 | $149,218 |
| 2020 | 13 | 958 | 1,239 | $306,728 | $97,900 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 323 | 323 | $116,775 | $50,553 | 43.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 282 | 625 | $224,494 | $47,251 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 227 | $83,750 | $22,703 | 27.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 127 | 198 | $52,679 | $9,966 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 83 | $22,655 | $4,989 | 22.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $12,097 | $4,711 | 38.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 61 | 61 | $10,399 | $4,619 | 44.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $9,434 | $3,678 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $10,342 | $3,228 | 31.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $7,919 | $2,968 | 37.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $4,718 | $2,599 | 55.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $3,100 | $1,062 | 34.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $1,070 | $594.24 | 55.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 48 | $3,349 | $552.89 | 16.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 12 | 12 | $603.38 | $85.26 | 14.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 329 | 709 | $323,802 | $57,486 | 17.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 175 | 175 | $81,986 | $27,314 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 232 | $106,045 | $22,600 | 21.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 182 | 280 | $90,631 | $16,774 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 117 | $37,706 | $7,585 | 20.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 54 | 54 | $10,761 | $3,782 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 21 | $11,204 | $3,253 | 29.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 20 | 20 | $7,846 | $2,643 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $3,640 | $2,118 | 58.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 35 | 35 | $2,411 | $790.19 | 32.8% |
About Dr. Steven Kaplan, M.D
Dr. Steven Kaplan, M.D is a Family Medicine healthcare provider based in Clayton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518073030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Kaplan, M.D has received a total of $8,325 in payments from pharmaceutical and medical device companies, with $551.53 received in 2024. These payments were reported across 518 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,300).
As a Medicare-enrolled provider, Kaplan has provided services to 4,495 Medicare beneficiaries, totaling 6,361 services with total Medicare billing of $552,119. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clayton, CA
- Active Since 08/21/2006
- Last Updated 03/29/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518073030
Products in Payments
- VRAYLAR (Drug) $563.74
- FARXIGA (Drug) $515.07
- Vascepa (Drug) $427.65
- NURTEC ODT (Drug) $407.51
- CHANTIX (Drug) $373.00
- UBRELVY (Drug) $338.21
- JARDIANCE (Drug) $336.94
- Saxenda (Drug) $273.03
- BREZTRI (Drug) $235.42
- SYMBICORT (Drug) $205.09
- APLENZIN (Drug) $183.93
- XYOSTED (Drug) $157.98
- Victoza (Drug) $138.02
- ELIQUIS (Drug) $134.35
- Ozempic (Drug) $132.05
- SOLIQUA (Drug) $129.30
- Repatha (Biological) $122.27
- OTREXUP (Drug) $117.17
- XARELTO (Drug) $114.26
- XIFAXAN (Drug) $112.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clayton
Bhavna Vaidya-Tank, Md, MD
Family Medicine — Payments: $11,671
Joan Meehan, Do, DO
Family Medicine — Payments: $11,035
Brian Pratt, Md, MD
Family Medicine — Payments: $9,650
Dr. William Hebda, M.d, M.D
Family Medicine — Payments: $4,334
Dr. Aaron Huizenga, D.o, D.O
Family Medicine — Payments: $4,229
Dr. Jana Tomsky, M.d, M.D
Family Medicine — Payments: $4,224